$106B Pfizer-AstraZeneca Offer Draws Global Scrutiny
Lawmakers across the globe are challenging Pfizer Inc.'s $106 billion offer for AstraZeneca PLC, claiming the deal would threaten competition, drug research and scientific jobs in the U.K. and Sweden....To view the full article, register now.
Already a subscriber? Click here to view full article